| RS2034511189 |
ANKRD11
|
Health Risk |
Likely pathogenic |
KBG syndrome, KBG syndrome |
| RS2034516672 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2034524807 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2034533882 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2034543510 |
RARA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2034556621 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS2034558502 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS2034558794 |
EIF2AK4
|
Health Risk |
Pathogenic |
EIF2AK4-related disorder, EIF2AK4-related disorder |
| RS2034559427 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, ANKRD11-related disorder |
| RS2034569713 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS2034579427 |
CEP290
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Meckel-Gruber syndrome |
| RS2034579709 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome 5, Senior-Loken syndrome 6 |
| RS2034580235 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS2034590529 |
ANKRD11
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2034595868 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2034603657 |
PIGN
|
Health Risk |
Pathogenic |
— |
| RS203462 |
AKAP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Reclassified - variant of unknown significance, AKAP10-related disorder |
| RS2034628748 |
TAF1
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS2034656569 |
PIGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2034677583 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2034681207 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2034687381 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2034687450 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2034687815 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2034687946 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2034688425 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034698276 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2034704908 |
GJC2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS2034739931 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Saldino-Mainzer syndrome |
| RS2034747055 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Saldino-Mainzer syndrome |
| RS2034767360 |
ATR
|
Health Risk |
Likely pathogenic |
— |
| RS2034767520 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2034773072 |
NALCN
|
Health Risk |
Pathogenic |
— |
| RS2034773322 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2034805244 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2034823903 |
KCNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Facial dysmorphism, hypertrichosis |
| RS2034829087 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2034835255 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2034841317 |
LOXHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2034844971 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Hereditary spastic paraplegia 74 |
| RS2034846986 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Hereditary spastic paraplegia 74 |
| RS2034849647 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS2034850724 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS2034852728 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Usher syndrome |
| RS2034854568 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034895916 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2034899344 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2034899784 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2034900559 |
USH2A
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS2034901738 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034905123 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034907262 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034908088 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2034908815 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2034909771 |
TPM1
|
Health Risk |
Likely pathogenic |
— |
| RS2034911718 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Y, Cardiovascular phenotype |
| RS2034915223 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2034916882 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2034919426 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2034926616 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2034934856 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2034937106 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2034937352 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2034938612 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034938852 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
USH2A-related disorder, Retinitis pigmentosa 39 |
| RS2034940102 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS2034941445 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034941684 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2034944843 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034946086 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034947671 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2034948574 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS2034949292 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034950420 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2034951427 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Usher syndrome type 2A |
| RS2034987478 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS2034988017 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS2034990430 |
TAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS2035000908 |
ANKRD11
|
Health Risk |
Likely pathogenic |
— |
| RS2035018293 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2035028859 |
ANKRD11
|
Health Risk |
Likely pathogenic |
Chromatinopathy, Chromatinopathy |
| RS2035039338 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2035067825 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS2035114607 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome 5, Intellectual disability |
| RS2035124136 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2035139741 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2035163592 |
PIEZO2
|
Health Risk |
Pathogenic |
— |
| RS2035180096 |
TGFB3
|
Health Risk |
Likely pathogenic |
Rienhoff syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2035184283 |
TGFB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Rienhoff syndrome |
| RS2035187622 |
NALCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS2035218747 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2035219369 |
PIEZO2
|
Health Risk |
Pathogenic |
Gordon syndrome, Gordon syndrome |
| RS2035236903 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2035287277 |
TGFB3
|
Health Risk |
Pathogenic |
Rienhoff syndrome, Rienhoff syndrome |
| RS2035287906 |
TGFB3
|
Health Risk |
Likely pathogenic |
Rienhoff syndrome, Arrhythmogenic right ventricular dysplasia 1 |
| RS2035293928 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Hereditary glaucoma |
| RS2035294180 |
TGFB3
|
Health Risk |
Conflicting classifications of pathogenicity |
TGFB3-related connective tissue disorders, Rienhoff syndrome |
| RS2035295129 |
TGFB3
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 1, Arrhythmogenic right ventricular dysplasia 1 |
| RS2035295556 |
LRRK1
|
Health Risk |
Pathogenic |
— |
| RS2035305918 |
COL18A1
|
Health Risk |
Pathogenic |
Hereditary glaucoma, primary closed-angle |